Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway.
about
MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistanceSequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells.Slug contributes to cancer progression by direct regulation of ERα signaling pathwayFractionated Ionizing Radiation Promotes Epithelial-Mesenchymal Transition in Human Esophageal Cancer Cells through PTEN Deficiency-Mediated Akt Activation.Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway.Twist1 is a potential prognostic marker for colorectal cancer and associated with chemoresistance.Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis.Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinomaNanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissueA comparison of epithelial-to-mesenchymal transition and re-epithelializationDeregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancerCarboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylationFluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells.Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway.ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition.The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma.Gastrointestinal Factor GDDR Attenuates Epithelial-Mesenchymal Transition in Gastric Cancer via Inhibiting AKT Signal.Transcriptional regulation, stabilization, and subcellular redistribution of multidrug resistance-associated protein 1 (MRP1) by glycogen synthase kinase 3αβ: novel insights on modes of cadmium-induced cell death stimulated by MRP1.Der p 2 promotes motility of airway epithelial cell attributing to AKT/GSK3β-associated epithelial-to-mesenchymal transition.A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity.Cisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changes.Coxsackie and adenovirus receptor is a critical regulator for the survival and growth of oral squamous carcinoma cells.Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature.Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-cateninLapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expression.MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.[Epithelial-mesenchymal transition and tumor drug resistance].lncRNA H19 is involved in TGF-β1-induced epithelial to mesenchymal transition in bovine epithelial cells through PI3K/AKT Signaling Pathway.Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC.Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins.Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma.Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.Signaling pathways and mesenchymal transition in pediatric high-grade glioma.
P2860
Q28538690-024393A9-079F-4509-9E2E-995804F92C80Q35028765-4C6A150B-23CA-41B2-912C-F2FC63408659Q35168129-4C802B7A-94A9-44CC-BFBD-79F785D1ED04Q35639341-7E044915-48C3-4605-86CA-A32997E7ECFEQ35674606-5774D32E-FD49-4999-900E-D319BD7AACBAQ35929842-8550D1A0-45A9-4C17-997E-ECF91B235B8FQ36145584-C95DB51F-5C42-407A-B35E-EBBEEA91875CQ36293901-DCF807F8-74ED-4FDF-BA3F-C4A013F597D6Q36413222-DE9E2936-EFB9-488F-BBBA-BA20B5E07AA1Q36443572-E6FCEE3C-0D46-4F8B-9CE1-45E055063E0DQ36678367-0C6F2B7C-73FC-433B-80F7-46B871D03BB9Q36689033-767B1E38-12BA-4342-A714-CFB8647A014DQ36906346-2BB60234-2AE1-4D83-BA3D-F0EE18F90798Q37027400-A19EB547-DBC5-4E44-948C-2E01CC4B4E6CQ37362793-10A7E24E-FD2F-494A-A37E-AC8034966570Q37652592-ED4477F9-6371-4CB5-82BB-C74E7129E660Q37661108-8BE44318-E0B4-45A7-9FE5-EAF12B3DFEAFQ38175044-DF2B1F4C-53DD-4062-B23C-796955DBEF43Q38206587-A4931D11-D060-4883-A6F1-A7F9795FE9A8Q38719813-7F435A64-0622-41A2-84A1-769C1222A64BQ38736933-AAD5F5FB-36B6-4A91-9210-4A092D983F46Q38780452-41B60823-9EEC-494E-8D65-D7026ECDD0F3Q38783041-F4579F70-F7C8-489A-820D-01D68C425C5DQ38951596-201D4276-9B6D-4371-B594-FFF0461CF7E5Q38984232-C00F098C-D82C-411E-A339-B6B60CFAD48BQ39133025-2D42FEC6-F4AA-472F-A06F-B0A3C67BD281Q39169544-5E7AA014-E037-4D1D-9169-ECA7D8C2A719Q39179642-D8E764C8-6C5F-42BD-9A36-C1E8806F668AQ39223173-D9E89A0A-7170-42DB-82EC-20B8B1F40AA7Q39224654-B348A1D5-C0F6-4E47-A86B-F2A6F1F22CB7Q39252635-1FC238E6-6BC6-4931-97FC-4EA7F21A5D20Q39648267-324F9179-2F0F-4300-AE73-BC5B80C51865Q42371545-E5EF9679-1242-4623-B1A8-8BA21A25ACA6Q44267680-090B4584-8A4B-4F47-82B8-EF9A4F1EAA1DQ45451247-9FEF8FC4-E01A-4FED-A220-DE7578CA6017Q47119773-CD92B570-6D63-4483-92DF-CD6F1F4B83D3Q47790409-56AC7D7F-3CAA-4638-A613-67663C4F42BCQ47927666-84FF3BB6-C9A4-49AD-BA91-67A1886DA1F1Q48132559-DCE42A25-3E0B-474E-83AD-82C4C3E7C960Q48258004-67AE78D2-E096-46AE-972D-536E9757ECFB
P2860
Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Acquisition of EMT phenotype i ...... K-3β/snail signalling pathway.
@en
Acquisition of EMT phenotype i ...... K-3β/snail signalling pathway.
@nl
type
label
Acquisition of EMT phenotype i ...... K-3β/snail signalling pathway.
@en
Acquisition of EMT phenotype i ...... K-3β/snail signalling pathway.
@nl
prefLabel
Acquisition of EMT phenotype i ...... K-3β/snail signalling pathway.
@en
Acquisition of EMT phenotype i ...... K-3β/snail signalling pathway.
@nl
P2093
P2860
P356
P1476
Acquisition of EMT phenotype i ...... K-3β/snail signalling pathway.
@en
P2093
H Nakanishi
S Murakami
P2860
P2888
P304
P356
10.1038/BJC.2012.24
P407
P577
2012-02-07T00:00:00Z
P5875
P6179
1031279927